Gynecologic Cancer Survivorship Survey: What We Learned

Recorded on May 25, 2023 
Duration approximately 1 hour

Join IGCS-IGCAN Advocacy Committee Members with special guests for a Patient Perspectives Roundtable webinar on May 25.

As we continue our recognition of World Ovarian Cancer Day throughout the month of May, Dr. Abhishek Shankar will provide an executive summary of the IGCS-IGCAN Gynecologic Cancer Survivorship Care Survey which was conducted earlier this year. Over 400 gynecologic cancer survivors worldwide completed the survey which included questions to help us understand their journey with the intention to develop robust and effective gynecologic cancer survivorship care plans.

We are honored to host this roundtable discussion with ovarian cancer survivors, Manisha Koirala and Eva-Maria Stromsholm who will provide their insights on survivorship care and the supportive needs of cancer patient-survivors.

Special Guest Panelists

Manisha Koirala
Ovarian Cancer Survivor
Public Figure/Actress/Author

Eva-Maria Stromsholm, MS, RN
Rare Ovarian Cancer Survivor
Co-founder and Vice Chair of Gynecological Cancer Patients in Finland; Co-founder and member of the Nordic Gynecologic Patient Organizations Network


Daniela Luvero, MD
IGCS Advocacy Committee Chair
Gynecologic Oncologist, University Campus Bio Medico of Rome

Rosalind Glasspool, MD
IGCS Advocacy Committee Vice Chair
Medical Oncologist
NHS Greater Glasgow and Clyde and University of Glasgow

Abhishek Shankar, MD
IGCS Advocacy Committee Member
Radiation Oncologist
Secretary, Indian Society of Clinical Oncology; Assistant Professor, Department of Radiation Oncology, AIIMS, New Delhi


Sponsored in part by GSK.

Advocate Membership

If you would like to join the IGCAN to be notified when the recordings are available and receive additional updates from the IGCAN, please sign up as an “Advocate Member” on the IGCS website here. Please note that Advocate Membership is complimentary and Advocate Members do not receive the same benefits as Full IGCS Members.

Leave a Reply